Target intelligence / Profile preview

Keratin (KRT)

Target
KRT
Molecular classification
Structural protein, Intermediate filament, Other
01

Overview

Keratin is a family of fibrous structural proteins that form the primary constituent of the stratum corneum, the outermost layer of the epidermis (UniProt, 2023). In the stratum corneum, keratin filaments are bundled together and embedded in a lipid matrix, providing mechanical strength and a water-impermeable barrier for the skin (StatPearls, 2023). Hyperkeratosis occurs when there is an abnormal accumulation of keratin, resulting in a thickened, often scaly or hard skin surface seen in conditions like psoriasis, ichthyosis, and common calluses (Mayo Clinic, 2024). Therapeutic intervention typically involves the use of keratolytic agents, which target the keratin structure or the desmosomal attachments between corneocytes (PubChem, 2024). These drugs, such as salicylic acid and urea, act by softening the keratin and promoting the desquamation of the excess tissue, thereby restoring normal skin texture and function (Journal of Clinical and Aesthetic Dermatology, 2021).

Other names
CytokeratinIntermediate filament proteinCorneocyte keratinHard keratinSoft keratinKeratin in hyperkeratotic stratum corneum
02

Mechanism of action

Keratolytic agents work by increasing the moisture content of the skin and dissolving the intercellular cement (desmosomes) that holds the cells of the stratum corneum together, or by directly denaturing and breaking down keratin filaments, thereby facilitating the shedding of hyperkeratotic scales (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Structural integrityEpidermal barrier functionProtection against mechanical stressWater retentionOther
04

Disease associations

HyperkeratosisPsoriasisIchthyosisActinic keratosisCallusVerruca vulgarisAcne vulgarisKeratosis pilarisOther
05

Safety considerations

Skin irritationErythemaChemical burnsSystemic toxicity (e.g., salicylism with extensive use of salicylic acid)Increased photosensitivity
06

Interacting drugs

Salicylic acid

7 more in the full profile.

07

Biomarkers

Stratum corneum thicknessKeratin 1 (KRT1) expressionKeratin 10 (KRT10) expressionTransepidermal water loss (TEWL)

Beyond the preview

Go deeper on Keratin (KRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin (KRT).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call